Search

Kenalog to Identify Vitreous Gel

Show Description +

Xenon 25g Kenalog PVD Induction

Posted: 2/22/2008

Up Next

[2019] Amniotic Membrane Placement for Repair of Recurrent Macular Hole

[2019] Amniotic Membrane Placement for Repair of Recurrent Macular Hole

Stanislao Rizzo, MD

Pinhole Effect in Double Peel for Macular Hole

Pinhole Effect in Double Peel for Macular Hole

Hudson de Carvalho Nakamura, MD

Triple Procedure With Chronic Macular Hole, Subluxated IOL, and Retinal Detachment

Triple Procedure With Chronic Macular Hole, Subluxated IOL, and Retinal Detachment

Frederic Aissani, MD

Macular Hole Surgery: Retinal Massager

Macular Hole Surgery: Retinal Massager

Manish Nagpal, MS, DO, FRCS(UK)

Iatrogenic Macular Hole After TPA Injection for Submacular Hemorrhage

Iatrogenic Macular Hole After TPA Injection for Submacular Hemorrhage

Frederic Aissani, MD

The Big Mac: ILM Technique for Large Macular Holes

The Big Mac: ILM Technique for Large Macular Holes

Hudson Nakamura, MD

ILM Peel for Macular Hole Under Liquid PFC

ILM Peel for Macular Hole Under Liquid PFC

Hudson Nakamura, MD

My Peeling Technique for a Dense Plaque on the Posterior Capsule

My Peeling Technique for a Dense Plaque on the Posterior Capsule

Ashraf Armia, FRCSG, FACS

Experience a New Dimension: How Eyetube3D Works!

Experience a New Dimension: How Eyetube3D Works!

25-Gauge Vitrectomy for Retained Lens Fragments

25-Gauge Vitrectomy for Retained Lens Fragments

Yoreh Barak, MD, Lana Rifkin, MD, Omar Saleh, MD, Shlomit Schaal, MD, PhD

Kenalog to Identify Vitreous Gel

Xenon 25g Kenalog PVD Induction

Posted: 2/22/2008

Please log in to leave a comment.

More in Retina

Vitreous Sensing Vitrectomy

Vitreous Sensing Vitrectomy

Maria Berrocal, MD and Jordan Deaner, MD

Effect of Imaging on Stress in Pre-Term ROP Patients

Effect of Imaging on Stress in Pre-Term ROP Patients

Angela Li, MD

Recalcitrant Retinal Detachment

Recalcitrant Retinal Detachment

Frédéric Aissani, MD

Treating GA with Avacincaptad Pegol: 3.5-Year Data

Treating GA with Avacincaptad Pegol: 3.5-Year Data

Peter K. Kaiser, MD